866-997-4948(US-Canada Toll Free)

Global Orphan Drugs Sales Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 116 Pages

In this report, the global Orphan Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Orphan Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Orphan Drugs market competition by top manufacturers/players, with Orphan Drugs sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer
Bristol-Myers Squibb
Novartis
Pfizer
Roche
Sanofi
Johnson & Johnson
Eli Lilly & Co.
Celgene
Biogen IDEC
Pharmacyclics
Vertex
Onyx
AstraZeneca
Baxter
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
New Molecular Entities Drugs
Biologics Drugs
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Orphan Drugs for each application, including
Oncologic
Metabolic
Hematologic-Immunologic
Infections/Parasitic
Other

Table of Contents

Global Orphan Drugs Sales Market Report 2017
1 Orphan Drugs Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs by Product Category
1.2.1 Global Orphan Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Orphan Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 New Molecular Entities Drugs
1.2.4 Biologics Drugs
1.2.5 Other
1.3 Global Orphan Drugs Market by Application/End Users
1.3.1 Global Orphan Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncologic
1.3.3 Metabolic
1.3.4 Hematologic-Immunologic
1.3.5 Infections/Parasitic
1.3.6 Other
1.4 Global Orphan Drugs Market by Region
1.4.1 Global Orphan Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Orphan Drugs Status and Prospect (2012-2022)
1.4.3 China Orphan Drugs Status and Prospect (2012-2022)
1.4.4 Europe Orphan Drugs Status and Prospect (2012-2022)
1.4.5 Japan Orphan Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Orphan Drugs Status and Prospect (2012-2022)
1.4.7 India Orphan Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Orphan Drugs (2012-2022)
1.5.1 Global Orphan Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Orphan Drugs Revenue and Growth Rate (2012-2022)

2 Global Orphan Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Orphan Drugs Market Competition by Players/Suppliers
2.1.1 Global Orphan Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Orphan Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Orphan Drugs (Volume and Value) by Type
2.2.1 Global Orphan Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Orphan Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Orphan Drugs (Volume and Value) by Region
2.3.1 Global Orphan Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Orphan Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Orphan Drugs (Volume) by Application

3 United States Orphan Drugs (Volume, Value and Sales Price)
3.1 United States Orphan Drugs Sales and Value (2012-2017)
3.1.1 United States Orphan Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Orphan Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Orphan Drugs Sales Price Trend (2012-2017)
3.2 United States Orphan Drugs Sales Volume and Market Share by Players
3.3 United States Orphan Drugs Sales Volume and Market Share by Type
3.4 United States Orphan Drugs Sales Volume and Market Share by Application

4 China Orphan Drugs (Volume, Value and Sales Price)
4.1 China Orphan Drugs Sales and Value (2012-2017)
4.1.1 China Orphan Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Orphan Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Orphan Drugs Sales Price Trend (2012-2017)
4.2 China Orphan Drugs Sales Volume and Market Share by Players
4.3 China Orphan Drugs Sales Volume and Market Share by Type
4.4 China Orphan Drugs Sales Volume and Market Share by Application

5 Europe Orphan Drugs (Volume, Value and Sales Price)
5.1 Europe Orphan Drugs Sales and Value (2012-2017)
5.1.1 Europe Orphan Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Orphan Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Orphan Drugs Sales Price Trend (2012-2017)
5.2 Europe Orphan Drugs Sales Volume and Market Share by Players
5.3 Europe Orphan Drugs Sales Volume and Market Share by Type
5.4 Europe Orphan Drugs Sales Volume and Market Share by Application

6 Japan Orphan Drugs (Volume, Value and Sales Price)
6.1 Japan Orphan Drugs Sales and Value (2012-2017)
6.1.1 Japan Orphan Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Orphan Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Orphan Drugs Sales Price Trend (2012-2017)
6.2 Japan Orphan Drugs Sales Volume and Market Share by Players
6.3 Japan Orphan Drugs Sales Volume and Market Share by Type
6.4 Japan Orphan Drugs Sales Volume and Market Share by Application

7 Southeast Asia Orphan Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Orphan Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Orphan Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Orphan Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Orphan Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Orphan Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Orphan Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Orphan Drugs Sales Volume and Market Share by Application

8 India Orphan Drugs (Volume, Value and Sales Price)
8.1 India Orphan Drugs Sales and Value (2012-2017)
8.1.1 India Orphan Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Orphan Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Orphan Drugs Sales Price Trend (2012-2017)
8.2 India Orphan Drugs Sales Volume and Market Share by Players
8.3 India Orphan Drugs Sales Volume and Market Share by Type
8.4 India Orphan Drugs Sales Volume and Market Share by Application

9 Global Orphan Drugs Players/Suppliers Profiles and Sales Data
9.1 Bayer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Orphan Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bayer Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Orphan Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bristol-Myers Squibb Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Novartis
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Orphan Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novartis Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Orphan Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Roche
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Orphan Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Roche Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Sanofi
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Orphan Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Sanofi Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Johnson & Johnson
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Orphan Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Johnson & Johnson Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Eli Lilly & Co.
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Orphan Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eli Lilly & Co. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Celgene
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Orphan Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Celgene Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Biogen IDEC
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Orphan Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Biogen IDEC Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Pharmacyclics
9.12 Vertex
9.13 Onyx
9.14 AstraZeneca
9.15 Baxter

10 Orphan Drugs Maufacturing Cost Analysis
10.1 Orphan Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Orphan Drugs
10.3 Manufacturing Process Analysis of Orphan Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Orphan Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Orphan Drugs Market Forecast (2017-2022)
14.1 Global Orphan Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Orphan Drugs Price and Trend Forecast (2017-2022)
14.2 Global Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Orphan Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Orphan Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Orphan Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Orphan Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Orphan Drugs Price Forecast by Type (2017-2022)
14.4 Global Orphan Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Orphan Drugs
Figure Global Orphan Drugs Sales Volume Comparison (K MT) by Type (2012-2022)
Figure Global Orphan Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure New Molecular Entities Drugs Product Picture
Figure Biologics Drugs Product Picture
Figure Other Product Picture
Figure Global Orphan Drugs Sales Comparison (K MT) by Application (2012-2022)
Figure Global Sales Market Share of Orphan Drugs by Application in 2016
Figure Oncologic Examples
Figure Metabolic Examples
Figure Hematologic-Immunologic Examples
Figure Infections/Parasitic Examples
Figure Other Examples
Figure Global Orphan Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Orphan Drugs Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Orphan Drugs Sales Volume (K MT) (2012-2017)
Table Global Orphan Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Global Orphan Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Orphan Drugs Sales Share by Players/Suppliers
Figure 2017 Orphan Drugs Sales Share by Players/Suppliers
Figure Global Orphan Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Orphan Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Orphan Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Orphan Drugs Revenue Share by Players
Table 2017 Global Orphan Drugs Revenue Share by Players
Table Global Orphan Drugs Sales (K MT) and Market Share by Type (2012-2017)
Table Global Orphan Drugs Sales Share (K MT) by Type (2012-2017)
Figure Sales Market Share of Orphan Drugs by Type (2012-2017)
Figure Global Orphan Drugs Sales Growth Rate by Type (2012-2017)
Table Global Orphan Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Orphan Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Type (2012-2017)
Figure Global Orphan Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Orphan Drugs Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Global Orphan Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Orphan Drugs by Region (2012-2017)
Figure Global Orphan Drugs Sales Growth Rate by Region in 2016
Table Global Orphan Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Orphan Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Region (2012-2017)
Figure Global Orphan Drugs Revenue Growth Rate by Region in 2016
Table Global Orphan Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Orphan Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Region (2012-2017)
Figure Global Orphan Drugs Revenue Market Share by Region in 2016
Table Global Orphan Drugs Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Global Orphan Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Orphan Drugs by Application (2012-2017)
Figure Global Orphan Drugs Sales Market Share by Application (2012-2017)
Figure United States Orphan Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure United States Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Orphan Drugs Sales Price (USD/MT) Trend (2012-2017)
Table United States Orphan Drugs Sales Volume (K MT) by Players (2012-2017)
Table United States Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Orphan Drugs Sales Volume Market Share by Players in 2016
Table United States Orphan Drugs Sales Volume (K MT) by Type (2012-2017)
Table United States Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Orphan Drugs Sales Volume Market Share by Type in 2016
Table United States Orphan Drugs Sales Volume (K MT) by Application (2012-2017)
Table United States Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Orphan Drugs Sales Volume Market Share by Application in 2016
Figure China Orphan Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Orphan Drugs Sales Price (USD/MT) Trend (2012-2017)
Table China Orphan Drugs Sales Volume (K MT) by Players (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Players in 2016
Table China Orphan Drugs Sales Volume (K MT) by Type (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Type in 2016
Table China Orphan Drugs Sales Volume (K MT) by Application (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Europe Orphan Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Orphan Drugs Sales Price (USD/MT) Trend (2012-2017)
Table Europe Orphan Drugs Sales Volume (K MT) by Players (2012-2017)
Table Europe Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Orphan Drugs Sales Volume Market Share by Players in 2016
Table Europe Orphan Drugs Sales Volume (K MT) by Type (2012-2017)
Table Europe Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Orphan Drugs Sales Volume Market Share by Type in 2016
Table Europe Orphan Drugs Sales Volume (K MT) by Application (2012-2017)
Table Europe Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Japan Orphan Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Orphan Drugs Sales Price (USD/MT) Trend (2012-2017)
Table Japan Orphan Drugs Sales Volume (K MT) by Players (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Players in 2016
Table Japan Orphan Drugs Sales Volume (K MT) by Type (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Type in 2016
Table Japan Orphan Drugs Sales Volume (K MT) by Application (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Orphan Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume (K MT) by Players (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Orphan Drugs Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Orphan Drugs Sales Volume (K MT) by Application (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Application in 2016
Figure India Orphan Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Orphan Drugs Sales Price (USD/MT) Trend (2012-2017)
Table India Orphan Drugs Sales Volume (K MT) by Players (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Players in 2016
Table India Orphan Drugs Sales Volume (K MT) by Type (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Type in 2016
Table India Orphan Drugs Sales Volume (K MT) by Application (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Application in 2016
Table Bayer Basic Information List
Table Bayer Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Orphan Drugs Sales Growth Rate (2012-2017)
Figure Bayer Orphan Drugs Sales Global Market Share (2012-2017
Figure Bayer Orphan Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Orphan Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Orphan Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Orphan Drugs Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Orphan Drugs Sales Growth Rate (2012-2017)
Figure Novartis Orphan Drugs Sales Global Market Share (2012-2017
Figure Novartis Orphan Drugs Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Orphan Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Orphan Drugs Sales Global Market Share (2012-2017
Figure Pfizer Orphan Drugs Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Orphan Drugs Sales Growth Rate (2012-2017)
Figure Roche Orphan Drugs Sales Global Market Share (2012-2017
Figure Roche Orphan Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Orphan Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Orphan Drugs Sales Global Market Share (2012-2017
Figure Sanofi Orphan Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Orphan Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Orphan Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Orphan Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly & Co. Basic Information List
Table Eli Lilly & Co. Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly & Co. Orphan Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly & Co. Orphan Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly & Co. Orphan Drugs Revenue Global Market Share (2012-2017)
Table Celgene Basic Information List
Table Celgene Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Orphan Drugs Sales Growth Rate (2012-2017)
Figure Celgene Orphan Drugs Sales Global Market Share (2012-2017
Figure Celgene Orphan Drugs Revenue Global Market Share (2012-2017)
Table Biogen IDEC Basic Information List
Table Biogen IDEC Orphan Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biogen IDEC Orphan Drugs Sales Growth Rate (2012-2017)
Figure Biogen IDEC Orphan Drugs Sales Global Market Share (2012-2017
Figure Biogen IDEC Orphan Drugs Revenue Global Market Share (2012-2017)
Table Pharmacyclics Basic Information List
Table Vertex Basic Information List
Table Onyx Basic Information List
Table AstraZeneca Basic Information List
Table Baxter Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Players in 2016
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure Global Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Orphan Drugs Price (USD/MT) and Trend Forecast (2017-2022)
Table Global Orphan Drugs Sales Volume (K MT) Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Orphan Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure China Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Orphan Drugs Sales (K MT) Forecast by Type (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Orphan Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Orphan Drugs Price (USD/MT) Forecast by Type (2017-2022)
Table Global Orphan Drugs Sales (K MT) Forecast by Application (2017-2022)
Figure Global Orphan Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *